Pilot Study Freeze and Transport Immune Cells

National Institute of Allergy and Infectious Diseases (NIAID)12 enrolled

Overview

To evaluate and standardize umbilical cord specimen collection and laboratory procedures to evaluate cellular and serological immune responses in neonates and young infants

To evaluate: 1) The procedures for obtaining umbilical cord blood; 2) the methods for ensuring immune cell viability, freezing, and shipping; 3) the conditions for optimization of immune cell isolation procedures.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Diphtheria Hepatitis B Pertussis Poliomyelitis Tetanus

Eligibility

Sex: FEMALEMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: For the portion of the pilot study conducted at the UCLA CVR, an umbilical cord blood sample will be obtained from approximately 8 to 12 healthy pregnant women who are delivering neonates at the Obstetrical delivery ward of Harbor- UCLA Medical Center. Informed consent will not be obtained because the blood will be obtained after delivery from a clamped umbilical cord attached to the placenta (afterbirth) that otherwise would be discarded. Exclusion Criteria: A cord blood sample will not be collected from women who have requested special arrangements for a cord blood registry service.

Locations (1)

UCLA Center For Vaccine Research

Torrance, California, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.